A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.
Clinical trial NCT00269880 · COMPLETED
Trial details
- NCT number
- NCT00269880
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1995-02-01
- Primary completion
- 1995-12-01
- Enrollment
- 2792
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.